| PERIOD ENDING | 30-Nov-09 | 31-Aug-09 | 31-May-09 | 28-Feb-09 | | Total Revenue | 155,657 | 124,891 | 119,806 | 115,666 | | Cost of Revenue | 125,430 | 101,292 | 96,882 | 101,931 | | | Gross Profit | 30,227 | 23,599 | 22,924 | 13,735 | | | Operating Expenses | | Research Development | 2,542 | 2,205 | 2,072 | 2,303 | | Selling General and Administrative | 24,548 | 20,575 | 20,620 | 25,773 | | Non Recurring |
-
|
-
|
-
| 38,814 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,137 | 819 | 232 | (53,155) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 449 | 407 | 448 | (2,044) | | Earnings Before Interest And Taxes | 4,036 | 1,581 | 1,075 | (55,150) | | Interest Expense | 394 | 384 | 319 | 378 | | Income Before Tax | 3,642 | 1,197 | 756 | (55,528) | | Income Tax Expense | (9,003) | (1,578) | 283 | 14,493 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 13,846 | 2,775 | 473 | (70,021) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,645 | 2,775 | 473 | (70,021) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $12,645 | $2,775 | $473 | ($70,021) |
|
0.35% Nasdaq 
Income Statement
